SUPERNUS PHARMACEUTICALS, INC. Stock-Based Compensation
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Stock-Based Compensation of $17.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $8.64M, a 15.09% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $8.48M, a 5.11% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $9.65M, a 26.45% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $7.83M, a 1.97% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $33.05M, a 19.08% increase from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $27.75M, a 3.72% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $26.76M, a 52.32% increase from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $17.57M, a 1.91% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $17.12M 10-Q · filed 2026-08-03 | $26.77M derived: sum of 3 quarters · filed 2026-08-03 | $34.60M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $8.48M 10-Q · filed 2026-05-05 | $18.13M derived: sum of 2 quarters · filed 2026-05-05 | $25.96M derived: sum of 3 quarters · filed 2026-05-05 | $33.46M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $17.48M derived: sum of 2 quarters · filed 2026-03-02 | $24.98M derived: sum of 3 quarters · filed 2026-08-03 | $33.05M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $7.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.33M derived: sum of 2 quarters · filed 2026-08-03 | $23.40M 10-Q · filed 2025-11-06 | $31.03M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $7.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $15.57M 10-Q · filed 2026-08-03 | $23.21M derived: sum of 3 quarters · filed 2026-08-03 | $30.88M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $8.07M 10-Q · filed 2026-05-05 | $15.70M derived: sum of 2 quarters · filed 2026-05-05 | $23.37M derived: sum of 3 quarters · filed 2026-05-05 | $29.93M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $15.31M derived: sum of 2 quarters · filed 2026-03-02 | $21.86M derived: sum of 3 quarters · filed 2026-03-02 | $27.75M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $7.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.23M derived: sum of 2 quarters · filed 2025-11-06 | $20.12M 10-Q · filed 2025-11-06 | $26.57M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-06-30 | $6.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $12.45M 10-Q · filed 2025-08-05 | $18.89M derived: sum of 3 quarters · filed 2026-03-02 | $26.81M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-03-31 | $5.90M 10-Q · filed 2025-05-06 | $12.34M derived: sum of 2 quarters · filed 2026-03-02 | $20.26M derived: sum of 3 quarters · filed 2026-03-02 | $26.35M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2023-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $14.37M derived: sum of 2 quarters · filed 2026-03-02 | $20.45M derived: sum of 3 quarters · filed 2026-03-02 | $26.76M 10-K · filed 2026-03-02 | ||||
| 2023-09-30 | $7.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $14.01M derived: sum of 2 quarters · filed 2024-11-04 | $20.31M 10-Q · filed 2024-11-04 | $24.57M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $6.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $12.39M 10-Q · filed 2024-08-06 | $16.66M derived: sum of 3 quarters · filed 2025-02-25 | $21.64M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $6.31M 10-Q · filed 2024-05-08 | $10.57M derived: sum of 2 quarters · filed 2025-02-25 | $15.55M derived: sum of 3 quarters · filed 2025-02-25 | $19.85M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.25M derived: sum of 2 quarters · filed 2025-02-25 | $13.54M derived: sum of 3 quarters · filed 2025-02-25 | $17.57M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $4.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $9.28M derived: sum of 2 quarters · filed 2023-11-08 | $13.31M 10-Q · filed 2023-11-08 | $17.34M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.32M 10-Q · filed 2023-08-08 | $12.36M derived: sum of 3 quarters · filed 2023-08-08 | $16.39M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $4.03M 10-Q · filed 2023-05-09 | $8.06M derived: sum of 2 quarters · filed 2023-05-09 | $12.09M derived: sum of 3 quarters · filed 2023-05-09 | $17.56M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $8.06M derived: sum of 2 quarters · filed 2023-03-09 | $13.54M derived: sum of 3 quarters · filed 2023-03-09 | $17.91M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $4.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.50M derived: sum of 2 quarters · filed 2022-11-09 | $13.87M 10-Q · filed 2022-11-09 | $17.00M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2021-06-30 | $5.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $9.85M 10-Q · filed 2022-08-08 | $12.97M derived: sum of 3 quarters · filed 2023-03-09 | $17.46M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2021-03-31 | $4.37M 10-Q · filed 2022-05-12 | $7.49M derived: sum of 2 quarters · filed 2023-03-09 | $11.98M derived: sum of 3 quarters · filed 2023-03-09 | $16.94M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2020-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $7.61M derived: sum of 2 quarters · filed 2023-03-09 | $12.57M derived: sum of 3 quarters · filed 2023-03-09 | $16.56M 10-K · filed 2023-03-09 | ||||
| 2020-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $9.45M derived: sum of 2 quarters · filed 2021-11-05 | $13.44M 10-Q · filed 2021-11-05 | $17.06M derived: sum of 4 quarters · filed 2022-04-13 | ||||
| 2020-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $8.95M 10-Q · filed 2021-08-06 | $12.57M derived: sum of 3 quarters · filed 2022-04-13 | $16.49M derived: sum of 4 quarters · filed 2022-04-13 | ||||
| 2020-03-31 | $3.99M 10-Q · filed 2021-05-07 | $7.61M derived: sum of 2 quarters · filed 2022-04-13 | $11.53M derived: sum of 3 quarters · filed 2022-04-13 | $15.55M derived: sum of 4 quarters · filed 2022-04-13 | ||||
| 2019-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $7.54M derived: sum of 2 quarters · filed 2022-04-13 | $11.56M derived: sum of 3 quarters · filed 2022-04-13 | $14.85M 10-K · filed 2022-04-13 | ||||
| 2019-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $7.94M derived: sum of 2 quarters · filed 2020-11-06 | $11.22M 10-Q · filed 2020-11-06 | $14.21M derived: sum of 4 quarters · filed 2021-03-08 | ||||
| 2019-06-30 | $4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-17 | $7.31M 10-Q · filed 2020-08-17 | $10.30M derived: sum of 3 quarters · filed 2021-03-08 | $12.90M derived: sum of 4 quarters · filed 2021-03-08 | ||||
| 2019-03-31 | $3.29M 10-Q · filed 2020-05-15 | $6.28M derived: sum of 2 quarters · filed 2021-03-08 | $8.88M derived: sum of 3 quarters · filed 2021-03-08 | $11.94M derived: sum of 4 quarters · filed 2021-03-08 | ||||
| 2018-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $5.59M derived: sum of 2 quarters · filed 2021-03-08 | $8.66M derived: sum of 3 quarters · filed 2021-03-08 | $11.29M 10-K · filed 2021-03-08 | ||||
| 2018-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $5.67M derived: sum of 2 quarters · filed 2019-11-08 | $8.30M 10-Q · filed 2019-11-08 | $10.29M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $5.70M 10-Q · filed 2019-08-09 | $7.69M derived: sum of 3 quarters · filed 2020-02-28 | $10.05M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-03-31 | $2.63M 10-Q · filed 2019-05-10 | $4.62M derived: sum of 2 quarters · filed 2020-02-28 | $6.98M derived: sum of 3 quarters · filed 2020-02-28 | $9.24M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2017-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $4.35M derived: sum of 2 quarters · filed 2020-02-28 | $6.61M derived: sum of 3 quarters · filed 2020-02-28 | $8.43M 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $4.62M derived: sum of 2 quarters · filed 2018-11-09 | $6.45M 10-Q · filed 2018-11-09 | $7.92M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.09M 10-Q · filed 2018-08-09 | $5.56M derived: sum of 3 quarters · filed 2019-03-01 | $7.04M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $1.83M 10-Q · filed 2018-05-10 | $3.30M derived: sum of 2 quarters · filed 2019-03-01 | $4.78M derived: sum of 3 quarters · filed 2019-03-01 | $6.39M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.96M derived: sum of 2 quarters · filed 2019-03-01 | $4.57M derived: sum of 3 quarters · filed 2019-03-01 | $5.93M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.10M derived: sum of 2 quarters · filed 2017-11-09 | $4.45M 10-Q · filed 2017-11-09 | $5.53M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.97M 10-Q · filed 2017-08-03 | $4.05M derived: sum of 3 quarters · filed 2018-03-01 | $5.18M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $1.36M 10-Q · filed 2017-05-09 | $2.44M derived: sum of 2 quarters · filed 2018-03-01 | $3.57M derived: sum of 3 quarters · filed 2018-03-01 | $4.55M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $1.08M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $2.21M derived: sum of 2 quarters · filed 2018-03-01 | $3.19M derived: sum of 3 quarters · filed 2018-03-01 | $4.09M 10-K · filed 2018-03-01 | $4.23M 10-K · filed 2016-03-09 | |||
| 2015-09-30 | $1.13M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-01-20 | $2.11M derived: sum of 2 quarters · filed 2017-01-23 | $3.01M 10-Q/A · filed 2017-01-20 | $3.15M 10-Q · filed 2015-11-09 | $3.74M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $977.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-01-23 | $1.88M 10-Q/A · filed 2017-01-23 | $2.02M 10-Q · filed 2015-08-07 | $2.61M derived: sum of 3 quarters · filed 2017-03-16 | $3.42M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $902.00K 10-Q/A · filed 2017-01-20 | $901.00K 10-Q · filed 2015-05-06 | $1.63M derived: sum of 2 quarters · filed 2017-03-16 | $2.44M derived: sum of 3 quarters · filed 2017-03-16 | $3.09M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $732.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $1.54M derived: sum of 2 quarters · filed 2017-03-16 | $2.19M derived: sum of 3 quarters · filed 2017-03-16 | $2.86M 10-K · filed 2017-03-16 | $2.72M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | $806.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $1.46M derived: sum of 2 quarters · filed 2017-01-20 | $2.13M 10-Q/A · filed 2017-01-20 | $2.02M 10-Q · filed 2014-11-12 | $2.78M derived: sum of 4 quarters · filed 2017-01-20 | |||
| 2014-06-30 | $652.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.32M 10-Q · filed 2015-08-07 | $1.97M derived: sum of 3 quarters · filed 2017-01-20 | $2.46M derived: sum of 4 quarters · filed 2017-01-20 | ||||
| 2014-03-31 | $667.00K 10-Q · filed 2015-05-06 | $1.32M derived: sum of 2 quarters · filed 2017-01-20 | $1.81M derived: sum of 3 quarters · filed 2017-01-20 | $2.24M derived: sum of 4 quarters · filed 2017-01-20 | ||||
| 2013-12-31 | $653.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | $1.14M derived: sum of 2 quarters · filed 2017-01-20 | $1.58M derived: sum of 3 quarters · filed 2017-01-20 | $1.91M 10-K/A · filed 2017-01-20 | ||||
| 2013-09-30 | $491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $923.00K derived: sum of 2 quarters · filed 2014-11-12 | $1.26M 10-Q · filed 2014-11-12 | $1.47M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $432.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $769.00K 10-Q · filed 2014-08-12 | $977.00K derived: sum of 3 quarters · filed 2015-03-12 | $1.11M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $337.00K 10-Q · filed 2014-05-13 | $545.00K derived: sum of 2 quarters · filed 2015-03-12 | $675.00K derived: sum of 3 quarters · filed 2015-03-12 | $728.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $338.00K derived: sum of 2 quarters · filed 2015-03-12 | $391.00K derived: sum of 3 quarters · filed 2015-03-12 | $443.00K 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $183.00K derived: sum of 2 quarters · filed 2013-11-13 | $235.00K 10-Q · filed 2013-11-13 | $197.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2012-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $105.00K 10-Q · filed 2013-08-14 | $67.00K derived: sum of 3 quarters · filed 2014-03-21 | $115.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2012-03-31 | $52.00K 10-Q · filed 2013-05-15 | $14.00K derived: sum of 2 quarters · filed 2014-03-21 | $62.00K derived: sum of 3 quarters · filed 2014-03-21 | $110.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2011-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $10.00K derived: sum of 2 quarters · filed 2014-03-21 | $58.00K derived: sum of 3 quarters · filed 2014-03-21 | -$82.00K 10-K · filed 2014-03-21 | ||||
| 2011-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $96.00K derived: sum of 2 quarters · filed 2012-11-02 | -$44.00K 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$92.00K 10-Q · filed 2012-08-13 | ||||||
| 2011-03-31 | -$140.00K 10-Q · filed 2012-06-08 | |||||||
| 2010-12-31 | $297.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |